Highly skilled clinicians are burning out under administrative burdens. They spend 20 to 30 minutes documenting each visit, take work home to finish notes afterHighly skilled clinicians are burning out under administrative burdens. They spend 20 to 30 minutes documenting each visit, take work home to finish notes after

Eric C. Gardner: How to Drive AI Adoption in Healthcare Systems

Highly skilled clinicians are burning out under administrative burdens. They spend 20 to 30 minutes documenting each visit, take work home to finish notes after hours, and have less time for the part of medicine they trained for, putting hands on patients.

Eric C. Gardner has led strategy and innovation initiatives across major healthcare organizations, integrating AI into clinical and operational workflows because he believes AI is the answer to unlocking clinicians from these burdens.

When AI is positioned as something done to clinical teams rather than with them, resistance is inevitable. Driving AI adoption requires anchoring technology in real operational pain points, establishing clear governance from day one, and investing in change management as much as technology.

Anchor AI in Real Operational Pain Points

Start with a problem the frontline already has and cares about. Document the burden before implementing anything.

“You identify that problem and the AI will help clearly remove those frictions,” Gardner explains. “When you start working through the workflows and start implementing these things, and you remove that friction from the team, that really helps set an anchor for that technology.”

Common pain points include documentation processes, prior authorization work for specialty appointments, staffing efficiencies, and access constraints to actually seeing patients. When AI clearly addresses these burdens, adoption follows because clinicians experience immediate relief from work they never wanted to do in the first place.

Gardner has seen ambient documentation technology reduce post-appointment administrative work from 20 to 30 minutes to seconds. The software records patient encounters, filters out non-clinical conversation, and documents only clinically relevant information, including coding and orders. “The technology has advanced to where 99% of the documentation is spot on, exactly what the provider would have documented,” Gardner notes.

Providers still quality-check the output, but the cognitive and time burden disappear. This is clinicians getting hours back every week to focus on patients instead of typing.

Establish Clear Governance From Day One

The second step is bringing clinicians, IT, compliance, legal, and operations into the same conversation from the beginning.

“You define the data ownership, the risk threshold, and success metrics up front and align the team on this process so that it prevents rework in the future,” Gardner explains. “If you don’t have a clear objective and everyone understands where we’re going, then there tends to be a lot of rework that happens.”

Most healthcare organizations are clinician-led. They couldn’t do the work without clinicians, so having their buy-in early and ensuring they understand practical applications, guardrails to protect patients and providers, and clear rules about where humans remain in the loop builds organizational confidence that allows technology to scale.

Invest in Change Management

Technology adoption fails when organizations invest in software but not in the people who must use it.

“Invest in change management as much as you’re investing in the technology,” Gardner emphasizes. “Change is difficult for everyone, and that pushback is inevitable.”

Early in his career, a leader introduced Gardner to “Who Moved My Cheese,” a book about leading change management and understanding different personalities involved in change. Change management requires training, transparency, and communication so clinicians understand what’s happening, what the next steps are, and where the organization is going.

Gardner has worked with organizations implementing predictive analytics that synthesize hundreds of pages of patient history into digestible summaries. “Providers review a summary before they go into the room, and it’s like you’re talking to your best friend,” he explains. “You understand that they’ve had all these different things happen in their life, and the most recent scans or tests that were relevant to the visit, all that is pulled forward.”

Understanding a patient’s cancer journey across hundreds of pages, labs, and exams, digested into a paragraph or two, removes cognitive burden while enabling more intimate, informed conversations with patients. But only if clinicians trust the technology, which requires transparent communication about how it works and what safeguards exist.

Remove the Burden, Not the Humanity

“What really inspired me was that we’ve got fantastic folks, well-trained, highly skilled clinicians that are just so burdened with administrative tasks that they’re getting burnt out,” Gardner explains. “AI is really the answer to helping us unlock those burdens so they can focus on the fun parts of clinical care, putting hands on the patient, eyes on the patient, versus worrying about typing up a note.”

When AI works as intended, clinicians spend seconds reviewing documentation instead of 30 minutes typing notes. They walk into patient rooms fully informed about complex medical histories. They focus on patients instead of administrative tasks.

That’s not automation replacing humanity, it’s technology removing barriers so humanity can do what it does best.

Connect with Eric C. Gardner on LinkedIn for insights on AI adoption in healthcare systems.

Comments
Market Opportunity
Chainbase Logo
Chainbase Price(C)
$0.09297
$0.09297$0.09297
-1.28%
USD
Chainbase (C) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Solana Tokenized RWAs Surge 10% to $873.3M: How Blockchain’s Revolutionary Growth Captures Real-World Value

Solana Tokenized RWAs Surge 10% to $873.3M: How Blockchain’s Revolutionary Growth Captures Real-World Value

BitcoinWorld Solana Tokenized RWAs Surge 10% to $873.3M: How Blockchain’s Revolutionary Growth Captures Real-World Value The value of tokenized real-world assets
Share
bitcoinworld2026/01/02 13:10
Mark Cuban, Dallas Mavericks Cleared Of Lawsuit Linked To Promotion Of Bankrupt Crypto Company

Mark Cuban, Dallas Mavericks Cleared Of Lawsuit Linked To Promotion Of Bankrupt Crypto Company

A lawsuit accusing billionaire entrepreneur Mark Cuban and the NBA team Dallas Mavericks of defrauding investors by promoting a now-bankrupt cryptocurrency lender
Share
Coinstats2026/01/02 12:12
First U.S. XRP ETF Launches Sept. 18, CME to List Options on XRP Futures Oct. 13

First U.S. XRP ETF Launches Sept. 18, CME to List Options on XRP Futures Oct. 13

XRP is drawing fresh attention from traditional finance as new products roll out in both securities and derivatives markets, broadening access points for exposure to the token.At the time of writing, according to CoinDesk Data, XRP was trading around $3.0263, down nearly 1% over the past 24 hours.On Sept. 18, REX Shares and Osprey Funds will debut the first U.S.-listed exchange-traded funds (ETFs) tied to XRP and Dogecoin (DOGE) on the Cboe BZX Exchange, under the tickers XRPR and DOJE. These products are not entirely “pure” spot funds, however. Bloomberg Intelligence analyst James Seyffart wrote on X that the funds aren’t “pure” spot products. Instead, they are structured to hold XRP and DOGE directly, while also investing in other spot ETFs from outside the U.S. to achieve exposure. Their filings also include language that would allow the use of derivatives for exposure if needed, though Seyffart emphasized that this is not the primary approach.The structure reflects the realities of building regulated crypto ETFs in the U.S., where sponsors have sometimes layered in indirect exposure. Even so, the launches mark the first time American brokerage accounts will have access to XRP- and DOGE-focused ETFs, expanding beyond bitcoin and ether, which dominate the ETF landscape.Less than a month later, CME Group plans to deepen its crypto derivatives lineup by listing options on XRP and Solana (SOL) futures, targeted for Oct. 13 pending regulatory review. Options will be listed on both the standard contracts and their smaller “micro” versions, designed to serve institutions, trading desks, and active individuals alike. Expiry choices will include every business day, each month, and each quarter, creating a wider term structure for managing exposures.The exchange said the decision follows strong growth in its newer altcoin futures. Since March, SOL futures have logged over 540,000 contracts traded (about $22.3 billion notional), while XRP futures, introduced in May, have seen more than 370,000 contracts change hands (roughly $16.2 billion notional). Market participants including Cumberland and FalconX welcomed the additions, citing the need for hedging tools beyond bitcoin and ether.Headquartered in Chicago, CME Group runs the world’s largest regulated derivatives marketplace, where listed crypto futures and options allow participants to hedge positions with central clearing and margining. Adding XRP and SOL options builds on the firm’s progression from bitcoin and ether into a wider set of liquid tokens.
Share
Coinstats2025/09/18 05:30